Home/Filings/4/0000320017-18-000076
4//SEC Filing

LOSORDO DOUGLAS W 4

Accession 0000320017-18-000076

CIK 0000320017other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:25 PM ET

Size

6.7 KB

Accession

0000320017-18-000076

Insider Transaction Report

Form 4
Period: 2018-06-20
LOSORDO DOUGLAS W
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2018-06-20$8.64/sh+13,300$114,912100,389 total
  • Tax Payment

    Common Stock

    2018-06-20$8.64/sh6,407$55,35693,982 total
Footnotes (2)
  • [F1]Reflects 13,300 in performance rights, the criteria for which was satisfied on April 6, 2018 and which vested in full on June 20, 2018, when the shareholders voted to approve the new 2018 Equity Incentive Compensation Plan.
  • [F2]Includes 42,763 shares of unvested restricted stock.

Issuer

CALADRIUS BIOSCIENCES, INC.

CIK 0000320017

Entity typeother

Related Parties

1
  • filerCIK 0001583810

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:25 PM ET
Size
6.7 KB